| __timestamp | MiMedx Group, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 118223000 | 1777824000000 |
| Thursday, January 1, 2015 | 187296000 | 1807378000000 |
| Friday, January 1, 2016 | 245015000 | 1732051000000 |
| Sunday, January 1, 2017 | 321139000 | 1770531000000 |
| Monday, January 1, 2018 | 359111000 | 2097224000000 |
| Tuesday, January 1, 2019 | 299255000 | 3291188000000 |
| Wednesday, January 1, 2020 | 248234000 | 3197812000000 |
| Friday, January 1, 2021 | 258615000 | 3569006000000 |
| Saturday, January 1, 2022 | 267841000 | 4027478000000 |
| Sunday, January 1, 2023 | 321477000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and MiMedx Group, Inc. have showcased contrasting revenue trajectories from 2014 to 2023. Takeda, a global leader, has seen its revenue soar by approximately 140%, reaching a staggering $4.26 trillion in 2023. This growth underscores Takeda's strategic expansions and robust product pipeline.
Conversely, MiMedx Group, Inc., a smaller player, experienced a more modest revenue increase of around 170% over the same period, peaking at $321 million in 2023. Despite its smaller scale, MiMedx's consistent growth highlights its niche market strength and innovative product offerings.
While Takeda's revenue dwarfs that of MiMedx, both companies exemplify resilience and adaptability in a competitive market. Notably, data for 2024 is incomplete, leaving room for speculation on future trends.
Comparing Revenue Performance: Eli Lilly and Company or MiMedx Group, Inc.?
Annual Revenue Comparison: Johnson & Johnson vs MiMedx Group, Inc.
Revenue Showdown: AstraZeneca PLC vs Takeda Pharmaceutical Company Limited
Amgen Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Merus N.V.?
Takeda Pharmaceutical Company Limited and Novavax, Inc.: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Telix Pharmaceuticals Limited vs MiMedx Group, Inc.
ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Travere Therapeutics, Inc. vs MiMedx Group, Inc.: Annual Revenue Growth Compared